REPROS THERAPEUTICS INC. (CIK: 0000897075) EDGAR, Information, Filings... CompaniesBIO.Com

REPROS THERAPEUTICS INC.

Mailing address
2408 TIMBERLOCH PLACE B-7, THE WOODLANDS, Delaware, 77380
Phone
2817193400
State location
Texas
State of incorporation
Delaware
Fiscal year end
December 31
SIC
2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Filings
N/A

REPROS THERAPEUTICS INC. (CIK: 0000897075) is an American company incorporated in the state of Texas. Head office is located at 2408 TIMBERLOCH PL, SUITE B-7, WOODLANDS, Texas, 77380. Work in the industry 2836 - (CF Office: Office of Life Sciences) BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES). REPROS THERAPEUTICS INC. is a public company and trade via Over-The-Counter (OTC).

Old names:

REPROS THERAPEUTICS INC from 2006-04-May to 2006-04-May
ZONAGEN INC from 1996-16-Oct to 2006-02-May

Owner	Filings	Transaction Date	Type of Owner
Dillaha Larry	0001360463	Feb-01-2017	officer: Interim President and CEO
Thompson Jaye	0001476971	Jul-05-2016	officer: See Remarks
FOURTEAU PATRICK	0001235637	May-12-2016	director
Wernicke J. F.	0001568978	Jan-25-2016	officer: Chief Medical Officer
Masterson Nola E	0001305231	Jun-16-2014	director
Wyllie Michael	0001533834	Jun-16-2014	director
Ramasastry Saira	0001547959	Jun-16-2014	director
PODOLSKI JOSEPH	0001208491	Mar-26-2014	director, officer: President and CEO
Wiehle Ronald	0001385092	Mar-26-2014	officer: VP, Research and Development
CAIN DANIEL F	0001274244	Jan-10-2014	director
Suesserman Michael	0001596196	Dec-18-2013	director
Anderson Katherine	0001476301	Oct-10-2013	officer: Chief Financial Officer
Oliveira Steven Michael	0001358629	Apr-19-2011	10 percent owner
EDELMAN JOSEPH	0001164426	Mar-03-2011	10 percent owner
PERCEPTIVE ADVISORS LLC	0001224962	Feb-24-2011	10 percent owner
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD	0001249675	Feb-24-2011	10 percent owner
Howell Stephen B.	0001464306	May-20-2009	director
Lammers Paul	0001457289	Feb-18-2009	officer: President
REED JOHN C	0001181561	Sep-29-2008	director
Efficacy Capital, Ltd.	0001350855	Oct-16-2007	10 percent owner
Efficacy Biotech Master Fund Ltd.	0001366070	Oct-16-2007	10 percent owner
Efficacy Biotech Fund LTD	0001366071	Oct-16-2007	10 percent owner
Efficacy Biotech Fund L.P.	0001366073	Oct-16-2007	10 percent owner
Lappe Mark	0001366074	Oct-16-2007	10 percent owner
Kayyem Jon Faiz	0001366268	Oct-16-2007	10 percent owner
van As Andre MD, PhD	0001384301	Dec-16-2006	officer: Chief Medical Officer
Harder Jeffrey R	0001331042	Jun-21-2005	director
BENTSEN LLOYD M III	0001193411	Dec-31-2004	director
PLOTH LOUIS JR	0001197577	Sep-29-2004	director, officer: VP & Chief Financial Officer
FOURCROY JEAN L MD PHD MPH	0001272715	Sep-29-2004	director
LAVOTHA ZSOLT E	0001273859	Sep-29-2004	director
Poorvin David	0001305418	Sep-29-2004	director
BIOTECHNOLOGY VALUE FUND L P	0000918923	Jan-14-2004	other: See Footnotes (1) (2)
BVF PARTNERS L P/IL	0001055947	Jan-14-2004	10 percent owner, other: Indirect Beneficial Owner
BVF INC/IL	0001056807	Jan-14-2004	10 percent owner, other: Indirect Beneficial Owner
BIOTECHNOLOGY VALUE FUND II LP	0001102444	Jan-14-2004	other: See Footnotes (1) (2)
BVF INVESTMENTS LLC	0001132245	Jan-14-2004	other: See Footnotes (1) (2)
SUTTER MARTIN P	0001017832	May-09-2003	director
BLASNIK STEVE	0001195813	May-09-2003	director
MCINERNEY TIMOTHY	0001226020	May-09-2003	director

Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by REPROS THERAPEUTICS INC.

Filings	Format	Description	Filed/Effective	File/Film Number
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0001019056-19-000119 (34 Act) Size: KB	Feb-14-2019	005-52909 19603169
SC 13G/A	Document	Amendment to Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions Acc-no: 0000315066-18-001542 (34 Act) Size: KB	Feb-13-2018	005-52909 18600044
15-12B	Document	Notice of termination of registration of a class of securities under Section 12(b) Acc-no: 0001193125-18-037317 (34 Act) Size: KB	Feb-09-2018	001-15281 18589195
EFFECT	Document	Acc-no: 9999999995-18-000340 (33 Act) Size: KB	Feb-06-2018	333-184159 18579159
EFFECT	Document	Acc-no: 9999999995-18-000342 (33 Act) Size: KB	Feb-06-2018	333-219428 18579158
EFFECT	Document	Acc-no: 9999999995-18-000341 (33 Act) Size: KB	Feb-06-2018	333-197253 18579153
EFFECT	Document	Acc-no: 9999999995-18-000338 (33 Act) Size: KB	Feb-06-2018	333-163510 18579149
EFFECT	Document	Acc-no: 9999999995-18-000339 (33 Act) Size: KB	Feb-06-2018	333-167409 18579148
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-18-004789 ( Act) Size: 0 KB	Jan-31-2018
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-18-004787 ( Act) Size: 0 KB	Jan-31-2018
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-18-004784 ( Act) Size: 0 KB	Jan-31-2018
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-18-004781 ( Act) Size: 0 KB	Jan-31-2018
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-18-004779 ( Act) Size: 0 KB	Jan-31-2018
4	Document	Statement of changes in beneficial ownership of securities Acc-no: 0001144204-18-004777 ( Act) Size: 0 KB	Jan-31-2018
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001144204-18-004775 (33 Act) Size: KB	Jan-31-2018	333-39413 18561252
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001144204-18-004773 (33 Act) Size: KB	Jan-31-2018	333-58542 18561250
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001144204-18-004770 (33 Act) Size: KB	Jan-31-2018	333-122343 18561245
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001144204-18-004767 (33 Act) Size: KB	Jan-31-2018	333-175641 18561241
S-8 POS	Document	Post-effective amendment to a S-8 registration statement Acc-no: 0001144204-18-004762 (33 Act) Size: KB	Jan-31-2018	333-200370 18561232
POS AM	Document	Post-effective amendment to a registration statement that is not immediately effective upon filing Acc-no: 0001144204-18-004760 (33 Act) Size: KB	Jan-31-2018	333-197253 18561227

Recent 20 filings. View all REPROS THERAPEUTICS INC. filings

Overall rating 5.0

Aug 22, 2022

Pelisari

young lad who new his job ansered questions and new what was best for me.

Aug 22, 2022

Jean Bishop

Very good communication and delivery made within the timeframe I was advised of

Aug 22, 2022

Samuel Ejimofor

It's being easier working on the website. And I recommend, it's a great website

REPROS THERAPEUTICS INC. overview
REPROS THERAPEUTICS INC. job
REPROS THERAPEUTICS INC. stock
REPROS THERAPEUTICS INC. ownership
REPROS THERAPEUTICS INC. CEO
REPROS THERAPEUTICS INC. documents

Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.